C&R Research Inc. (KOSDAQ:359090)
South Korea · Delayed Price · Currency is KRW 772.00
-30.00 (-3.74%)
At close: Apr 2, 2026
C&R Research Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 64,982 | 59,689 | 55,102 | 48,473 | 43,171 | |
Revenue Growth (YoY) | 8.87% | 8.32% | 13.68% | 12.28% | 58.70% |
Gross Profit | 64,982 | 59,689 | 55,102 | 48,473 | 43,171 |
Selling, General & Admin | 59,335 | 53,324 | 46,308 | 41,806 | 35,680 |
Amortization of Goodwill & Intangibles | 352.15 | 148.62 | 554.12 | 139.81 | - |
Other Operating Expenses | 1,681 | 1,546 | 1,417 | 1,217 | 996.8 |
Operating Expenses | 63,597 | 56,058 | 48,869 | 43,673 | 37,420 |
Operating Income | 1,385 | 3,630 | 6,233 | 4,800 | 5,751 |
Interest Expense | -218.21 | -275.35 | -393.73 | -380.95 | -511.01 |
Interest & Investment Income | 247.32 | 368.05 | 330.52 | 246.16 | 5.22 |
Earnings From Equity Investments | -494.21 | -1,928 | -438.58 | -407.44 | -397.13 |
Currency Exchange Gain (Loss) | 68.13 | 65.78 | -17.65 | -12.57 | -55.56 |
Other Non Operating Income (Expenses) | 8.71 | 166.44 | 7.51 | -1.56 | -7,517 |
EBT Excluding Unusual Items | 996.32 | 2,027 | 5,721 | 4,244 | -2,724 |
Gain (Loss) on Sale of Investments | 7.7 | 1,891 | - | - | - |
Gain (Loss) on Sale of Assets | -3.53 | -7.5 | - | - | - |
Asset Writedown | - | -229.22 | 70 | -60.36 | - |
Pretax Income | 1,000 | 3,682 | 5,791 | 4,183 | -2,724 |
Income Tax Expense | -20.67 | 322.99 | 243.67 | 163.77 | 579.93 |
Earnings From Continuing Operations | 1,021 | 3,359 | 5,547 | 4,019 | -3,304 |
Earnings From Discontinued Operations | - | - | 13.04 | -91.86 | - |
Net Income to Company | 1,021 | 3,359 | 5,560 | 3,928 | -3,304 |
Minority Interest in Earnings | 1,564 | 479.7 | 2.58 | 1.15 | 3.47 |
Net Income | 2,586 | 3,839 | 5,563 | 3,929 | -3,301 |
Net Income to Common | 2,586 | 3,839 | 5,563 | 3,929 | -3,301 |
Net Income Growth | -32.64% | -30.99% | 41.59% | - | - |
Shares Outstanding (Basic) | 57 | 56 | 55 | 54 | 5 |
Shares Outstanding (Diluted) | 57 | 56 | 56 | 54 | 5 |
Shares Change (YoY) | 1.78% | 0.27% | 4.94% | 982.01% | 230.56% |
EPS (Basic) | 45.00 | 68.00 | 101.88 | 73.23 | -665.67 |
EPS (Diluted) | 45.00 | 68.00 | 99.90 | 73.23 | -666.00 |
EPS Growth | -33.82% | -31.93% | 36.42% | - | - |
Free Cash Flow | -3,238 | 2,126 | 3,319 | 1,651 | 1,002 |
Free Cash Flow Per Share | -56.36 | 37.67 | 58.95 | 30.77 | 202.05 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | 2.13% | 6.08% | 11.31% | 9.90% | 13.32% |
Profit Margin | 3.98% | 6.43% | 10.10% | 8.11% | -7.65% |
Free Cash Flow Margin | -4.98% | 3.56% | 6.02% | 3.41% | 2.32% |
EBITDA | 2,528 | 4,819 | 7,377 | 5,450 | 6,435 |
EBITDA Margin | 3.89% | 8.07% | 13.39% | 11.24% | 14.91% |
D&A For EBITDA | 1,144 | 1,189 | 1,145 | 649.67 | 683.56 |
EBIT | 1,385 | 3,630 | 6,233 | 4,800 | 5,751 |
EBIT Margin | 2.13% | 6.08% | 11.31% | 9.90% | 13.32% |
Effective Tax Rate | - | 8.77% | 4.21% | 3.91% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.